These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23640125)

  • 21. Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N.
    Liu X; Lagenaur LA; Simpson DA; Essenmacher KP; Frazier-Parker CL; Liu Y; Tsai D; Rao SS; Hamer DH; Parks TP; Lee PP; Xu Q
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3250-9. PubMed ID: 17005802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
    Zárate G; Nader-Macias ME
    Lett Appl Microbiol; 2006 Aug; 43(2):174-80. PubMed ID: 16869901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal Microbicide Film Combinations of Two Reverse Transcriptase Inhibitors, EFdA and CSIC, for the Prevention of HIV-1 Sexual Transmission.
    Zhang W; Hu M; Shi Y; Gong T; Dezzutti CS; Moncla B; Sarafianos SG; Parniak MA; Rohan LC
    Pharm Res; 2015 Sep; 32(9):2960-72. PubMed ID: 25794967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells.
    Naarding MA; Dirac AM; Ludwig IS; Speijer D; Lindquist S; Vestman EL; Stax MJ; Geijtenbeek TB; Pollakis G; Hernell O; Paxton WA
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3367-74. PubMed ID: 17005819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues.
    Ñahui Palomino RA; Vanpouille C; Laghi L; Parolin C; Melikov K; Backlund P; Vitali B; Margolis L
    Nat Commun; 2019 Dec; 10(1):5656. PubMed ID: 31827089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea mays strongly determine their eventual anti-HIV activity.
    Hoorelbeke B; Van Damme EJ; Rougé P; Schols D; Van Laethem K; Fouquaert E; Balzarini J
    Retrovirology; 2011 Feb; 8(1):10. PubMed ID: 21314946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly (4-styrenesulfonic acid-co-maleic acid) is an entry inhibitor against both HIV-1 and HSV infections - potential as a dual functional microbicide.
    Qiu M; Chen Y; Song S; Song H; Chu Y; Yuan Z; Cheng L; Zheng D; Chen Z; Wu Z
    Antiviral Res; 2012 Nov; 96(2):138-47. PubMed ID: 22940611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Uckun FM
    Mol Hum Reprod; 2005 Oct; 11(10):767-77. PubMed ID: 16254003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1.
    Rosenstein IJ; Stafford MK; Kitchen VS; Ward H; Weber JN; Taylor-Robinson D
    J Infect Dis; 1998 May; 177(5):1386-90. PubMed ID: 9593030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?
    Balzarini J
    Antivir Chem Chemother; 2007; 18(1):1-11. PubMed ID: 17354647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction.
    Groot F; Geijtenbeek TB; Sanders RW; Baldwin CE; Sanchez-Hernandez M; Floris R; van Kooyk Y; de Jong EC; Berkhout B
    J Virol; 2005 Mar; 79(5):3009-15. PubMed ID: 15709021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.
    Garcia-Vallejo JJ; Koning N; Ambrosini M; Kalay H; Vuist I; Sarrami-Forooshani R; Geijtenbeek TB; van Kooyk Y
    Int Immunol; 2013 Apr; 25(4):221-33. PubMed ID: 23291968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of HIV entry by carbohydrate-binding proteins.
    Balzarini J
    Antiviral Res; 2006 Sep; 71(2-3):237-47. PubMed ID: 16569440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells.
    Arrighi JF; Pion M; Garcia E; Escola JM; van Kooyk Y; Geijtenbeek TB; Piguet V
    J Exp Med; 2004 Nov; 200(10):1279-88. PubMed ID: 15545354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.
    Naarding MA; Ludwig IS; Groot F; Berkhout B; Geijtenbeek TB; Pollakis G; Paxton WA
    J Clin Invest; 2005 Nov; 115(11):3256-64. PubMed ID: 16239964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.
    Auwerx J; François KO; Covens K; Van Laethem K; Balzarini J
    Virology; 2008 Dec; 382(1):10-9. PubMed ID: 18930512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models.
    Berzi A; Reina JJ; Ottria R; Sutkeviciute I; Antonazzo P; Sanchez-Navarro M; Chabrol E; Biasin M; Trabattoni D; Cetin I; Rojo J; Fieschi F; Bernardi A; Clerici M
    AIDS; 2012 Jan; 26(2):127-37. PubMed ID: 22045343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
    Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
    J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.